aTyr Pharma, Inc. Share Price
NASDAQ: ATYR | Micro CapaTyr Pharma, Inc. Stock Performance
Open $0.54 | Prev. Close $0.56 | Circuit Range N/A |
Day Range $0.54 - $0.54 | Year Range $0.40 - $6.50 | Volume 2,579 |
Average Traded $0.54 |
aTyr Pharma, Inc. Share Price Today
As of 29 August 2026, aTyr Pharma, Inc.'s share price is $0.54. The stock opened at $0.54, compared to its previous close of $0.56. During today's trading session, aTyr Pharma, Inc.'s share price traded between $0.54 and $0.54, with an average price of $0.54. Over the past 52 weeks, the stock has recorded a high of $6.50 and a low of $0.40. In terms of performance, aTyr Pharma, Inc.'s share price has declined by 44.03% over the last six months and is down 90.02% on a year-on-year basis.
aTyr Pharma, Inc. Share Price Chart
aTyr Pharma, Inc. Stock Fundamentals & Key Indicators
Market Cap $49.76M | PE Ratio (TTM) -0.67 | Dividend Yield N/A |
EPS (TTM) $-0.80 | Revenue (TTM) $190000.00 | Return On Equity (TTM) -109.84% |
Profit Margin -39012.11% | Debt to Equity 0.22 | Quarterly Earnings Growth YoY -49.16% |
aTyr Pharma, Inc. Quarterly Profit & Loss
All figures in USD
aTyr Pharma, Inc. Annual Profit & Loss
All figures in USD
About aTyr Pharma, Inc.
aTyr Pharma, Inc., a clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States. Its lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase 3 clinical trial for the treatment of pulmonary sarcoidosis; and in Phase 1b/2a clinical trial to treat other interstitial lung diseases (ILDs), such as chronic hypersensitivity pneumonitis and connective tissue disease related ILD. The company is developing ATYR0101, a fusion protein derived from a domain of aspartyl-tRNA synthetase, which is in preclinical development for the treatment fibrosis; and ATYR0750, a domain of alanyl-tRNA synthetase for the treatment of liver disorders. It has collaboration and license agreement with Kyorin Pharmaceutical Co., Ltd. for the development and commercialization of efzofitimod for ILDs in Japan. aTyr Pharma, Inc. was incorporated in 2005 and is headquartered in San Diego, California.
aTyr Pharma, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $0.49 | $0.56 | +16.04% |
Jul 2026 | $0.60 | $0.48 | -20.53% |
Jun 2026 | $0.52 | $0.60 | +11.44% |
May 2026 | $0.83 | $0.54 | -32.75% |
Apr 2026 | $0.82 | $0.81 | +3.87% |
Mar 2026 | $0.94 | $0.78 | -18.83% |
Feb 2026 | $0.88 | $0.96 | +10.27% |
Jan 2026 | $0.76 | $0.87 | +11.58% |
Dec 2025 | $0.78 | $0.78 | -0.38% |
Nov 2025 | $0.87 | $0.78 | -11.36% |
Oct 2025 | $0.70 | $0.88 | +22.05% |
Sep 2025 | $5.54 | $0.72 | -86.55% |
ATYR Share Price FAQs
What is aTyr Pharma, Inc. share price today?
What is the 52 week high and 52 week low of aTyr Pharma, Inc. stock?
What is ATYR's market capitalisation today?
What is ATYR's net income for the last quarter?
What is the 5 year returns of ATYR?
What is the high & low stock price of ATYR today?
Can I buy ATYR shares in India?